ArticlePediatrics2025
STI Testing in Adolescent Males Presenting to an Emergency Department.
Article in Pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nasogastric Hydration Utilization in Bronchiolitis, an EMO Trial Observational Substudy.Hospital pediatrics · 2026Observational
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
backgroundRacial differences in Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) testing and screening are well documented among adolescent females; however, data on adolescent males are limited. We sought to compare racial and ethnic differences in CT/GC testing and screening among adolescent males presenting to a pediatric emergency department (ED).
methodsCross-sectional analysis of ED visits made by males aged 13 to 21 years at 2 urban pediatric hospital campuses between January 2021 to February 2023. The primary outcome was performance of CT/GC testing or screening. Multivariable logistic regression assessed racial and ethnic differences in CT/GC testing or screening, adjusting for age and ED site.
resultsAmong 17 244 ED visits, 643 (3.7%) included CT/GC testing or screening. Of the 473 (2.7%) visits by symptomatic males, 187 (39.5%) included CT/GC testing. Testing rates were higher in visits by non-Hispanic Black males compared with non-Hispanic white males (50.0% vs 11.8%; adjusted odds ratio [aOR], 3.3 [95% CI, 1.3-8.3]). Of the 16 771 visits by males with non-STI-related chief complaints, 456 (2.7%) included CT/GC screening. Screening rates were higher among visits by non-Hispanic Black males compared with non-Hispanic white males (3.5% vs 0.8%; aOR 3.1 [95% CI, 1.6-5.9]).
conclusionsThere were low rates of CT/GC testing overall; however, visits by non-Hispanic Black adolescent males were more likely to include both testing and screening compared with non-Hispanic white males. More research is needed to determine possible cause of this racial difference and to identify strategies to mitigate potential racial differences in CT/GC testing in the ED.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.